Cyclerion Therapeutics, Inc.
CYCN
$2.95
-$0.20-6.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.11% | -57.31% | -68.47% | -18.67% | -20.55% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.88% | -4.75% | -14.46% | -88.89% | -45.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 110.00% | 45.45% | -63.33% | -97.43% | -98.01% |
| Total Current Assets | -25.22% | -47.35% | -64.03% | -33.71% | -27.85% |
|
|
|||||
| Total Current Assets | -25.22% | -47.35% | -64.03% | -33.71% | -27.85% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -13.35% | -28.41% | -41.51% | -0.32% | -0.80% |
|
|
|||||
| Total Accounts Payable | -34.82% | -67.45% | -62.65% | -65.08% | -81.12% |
| Total Accrued Expenses | 0.00% | -64.90% | -74.21% | -85.32% | -84.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -72.05% | -44.25% | -72.78% | 16.57% | 15.00% |
| Total Other Current Liabilities | -72.05% | -44.25% | -72.78% | 16.57% | 15.00% |
| Total Current Liabilities | -25.95% | -65.24% | -70.10% | -74.09% | -80.87% |
|
|
|||||
| Total Current Liabilities | -25.95% | -65.24% | -70.10% | -74.09% | -80.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -25.95% | -65.24% | -70.10% | -74.09% | -80.87% |
|
|
|||||
| Common Stock & APIC | 0.65% | 0.23% | 0.22% | 0.23% | 2.16% |
| Retained Earnings | -1.11% | -1.16% | -2.02% | 1.11% | 0.06% |
| Treasury Stock & Other | -- | -- | -- | -- | 15.79% |
| Total Common Equity | -11.52% | -21.60% | -36.32% | 70.54% | 152.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.52% | -21.60% | -36.32% | 70.54% | 152.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.52% | -21.60% | -36.32% | 70.54% | 152.82% |
|
|
|||||